Research shows cell-type-specific bidirectional modulation of STN neurons can restore motor function in parkinsonian models, pointing toward more precise neuromodulation therapies. Learn more:  https://loom.ly/42iNZf0

Stay ahead of the science. Examine the latest approaches in Parkinson’s disease research, from α-synuclein biology to AI-driven patient stratification. https://loom.ly/5t7ZSPo

Get involved: If you are attending the upcoming #PASCongress, you can become a Social Media Ambassador. As an official Ambassador, you will encourage others to attend, share about sessions, and capture key moments from the event. Apply now: https://loom.ly/zArMcmE

Last chance: Register for the #PASCongress now for the best rates. pascongress.org/Register

Be careful about how you speak to patients with a possible functional disorder – minor adjustments in your language can make a big impact. Learn the proper approach. https://loom.ly/axmgg-4

Research shows that brain atrophy in the neurodegenerative disease multiple system atrophy is linked to mitochondrial dysfunction and oligodendrocyte-related processes, shedding light on MSA-specific mechanisms. https://loom.ly/ZFJYv9E

Join us for the #PASCongress to learn about Science, Symptoms, and Solutions in Movement Disorders Across the Americas. View the program-at-a-glance: https://loom.ly/lLFU9S8

This MDCP Review Article of the Year highlights the devastating, vaccine-preventable neurological syndrome linked to measles and underscores the need for awareness, early recognition, and prevention efforts. https://loom.ly/4DmWD-8

Visiting Trainee Grant Program applications now open. Apply now to gain valuable movement disorders training in another country. https://loom.ly/A6IlAJ4

Learn how genetic therapies are advancing care for Parkinson's disease, Huntington's disease, and rare metabolic disorders, from preclinical work to clinical trial updates. #PASCongress pascongress.org

“They were really seminal in describing this model of Parkinson's that really has been the gold standard in translational research over 40 years, nearly.” Susan Fox shares the many therapies and breakthroughs that sprang from this milestone MDS paper.

Renew your membership for 2026, so you can enrich your career with MDS connections, resources, and benefits. https://loom.ly/EJBg2vU

Register for the #PASCongress before January 9, 2026 for the best rates. mdscongress.org

Submit abstracts now: PD genetics, environment, and epidemiology. https://loom.ly/5t7ZSPo

"It was a unifying concept. People understood each other better." Günther Deuschl shares how a milestone MDS paper has guided our once-disjointed understanding of the most common movement disorder, and what that has meant for research over the past 2 decades.

The unexpected symptom that has the highest impact on quality of life for PwP — and how a shift in research methods helped us quantify it. https://loom.ly/pBIn-H8

This Movement Disorders Journal’s Review Article of the Year highlights how long-read sequencing and optical genome mapping are transforming neurodegenerative disease research. Read more: https://loom.ly/mHawZGc

Matt Stern reflects on the MDS Task Force that reshaped our definition of Parkinson's disease and set the foundation for research advancements in synuclein biomarkers.

People with Tourette syndrome often use complementary medicine practices or products to treat their tics, but what does the clinical evidence show? MDS’s Tic Disorders Study Group found that widespread study limitations stymie justifiable recommendations. https://loom.ly/nWJNx78

Mr. Victor McConvey discusses the difference in palliative care across the world and the importance of incorporating non-medical care practice into this process. Listen as he discusses the changes needed to integrate palliative care into routine practice. https://loom.ly/kK5nJ4U

"Dystonia is an evolving concept, and there have been many new developments." Joseph Jankovic discusses how he expects recent updates to the MDS definition of dystonia to influence clinical practice.

Practical insights to integrate clinical neurophysiology into diagnosis and practice. Read more: https://loom.ly/xmhAV5E

Researchers found that the combined presence of probable REM sleep behavior disorder and reduced sense of smell is highly specific for predicting post-mortem α-synuclein pathology, a hallmark of Parkinson’s disease and related synucleinopathies. Learn more: https://loom.ly/u-V-_Bw

Explore new insights in movement disorder hot topics like the dystonia classification, emerging biomarkers, and advances in neuromodulation in this #PASCongress session. pascongress.org

"It's a nice intellectual exercise, but I don't think it will work." Werner Poewe offers a behind-the-scenes look at the development of the groundbreaking algorithm for prodromal PD risk — and recalls how he and a skeptical colleague put it to the test. https://loom.ly/12WSeYI

Learn more about the new MDS president, David Burn—his journey, vision, and goals for MDS. https://loom.ly/vxj3wIo

Delve into advancements, discoveries, and trends across the field with leaders from your region at the #PASCongress in Houston, TX, USA. mdscongress.org

"This article represents one of the most significant advances in the diagnosis of Parkinson's disease.” Oscar Gershanik details why this 2015 paper is still the go-to in the clinic today. https://loom.ly/AtBoG0E

Just released: 2026 #PASCongress program-at-a-glance. View the scientific sessions: https://loom.ly/lLFU9S8#PASCongress

Now Open: 2026 Abstract Submissions for the #MDSCongress. https://loom.ly/22Jj9eo

Discover how a 1992 paper gave us early insights into vital questions about prodromal PD that we are still unraveling today. https://loom.ly/_c9qYPs

Join global experts for this in-depth 3-day analysis of the newest developments in PD. Space is limited - register soon! https://loom.ly/5t7ZSPo

“It just tells you what is the evidence, and then you have to mix that with your cultural background, your own personal experience” Christopher Goetz recounts an important turning point in clinical guidance in movement disorders and how we can continue to reshape our approach https://loom.ly/rZ6SVVU

Differentiating dystonic head tremor can be challenging. Dr. Jung Hwan Shin and Prof. Beomseok Jeon discuss how 2D video recordings measuring tremor rhythmicity and sinusoidality could be a promising clinical tool. https://loom.ly/p4nOHAs

Attendees in of the Advances in Technology and Artificial Intelligence Applications in Movement Disorders course in Madrid discovered how artificial intelligence (AI) and cutting-edge technologies are transforming the landscape of movement disorders.

Submit your Late-Breaking Abstract and highlight your novel research at the #PASCongress: https://loom.ly/zm_lMp8#PASCongress

"I think with this article, a sort of new era started in the Movement Disorder Society strategy." Claudia Trenkwalder explains how MDS set the standards for scientific rigor in assessments that have elevated trials, care, and treatment globally. https://loom.ly/TkekIMI

As the number of people with #PD and other movement disorders continues to grow, your involvement with MDS has never been more important. Renew for 2026 today. https://loom.ly/EJBg2vU#PD

Gene therapies have rapidly progressed in the past few years, with well over 20 therapies receiving government approval since 2020. Here is a snapshot of just a few investigational gene therapies for movement disorders, with many more in the pipeline.

Now open: 2026 Visiting Trainee Grant Program applications https://loom.ly/A6IlAJ4

"This has changed the face of our understanding of the condition." — Anthony Lang, outlining the sweeping impact of what he chose as MDS's most historic paper. 

Dr. Cynthia Comella and Dr. Oscar Gershanik sit down to discuss their appreciation for what MDS has to offer and the contributions they have been proud to give in return. https://loom.ly/aB9yaUA

Professors Carolyn Sue and Beomseok Jeon celebrate MDS' 40th anniversary by sharing how the Society has changed through their eyes, and impacts it has had on their careers. https://loom.ly/RbbETXc

" Less than being a science, medicine can be an art.” Francisco Cardoso shares about an innovative shift in the way we evaluate therapeutic options, and how it complements everyday clinical care.

MDS has shaped the landscape of care for 40 years — thanks to you. https://loom.ly/M760FiE

Did you know rare movement disorders are not that rare overall? They affect millions of people. Help raise awareness about these and dozens of other underrecognized disorders this #MoveDisorder Day, November 29.

MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress

MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress

MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress

MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress